Market Research Logo

Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analo

Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Glaucoma Treatment Market. The report analyzes the global glaucoma treatment market By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others) and By Sales Channel (Hospital Pharmacy, Retail Pharmacy, Others). The report analyzes the global glaucoma treatment market By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S., Canada, U.K, Germany, India, China, Japan and Brazil). The report assesses the glaucoma treatment market for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report “Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)”, global glaucoma treatment market is projected to display a robust growth represented by a CAGR of 4.81 % during 2018 – 2023.

The segment of Prostaglandin Analogs witnessed growth at a noteworthy rate over the past few years backed by increased prevalence of glaucoma, easy availability of dug along with rising number of hospitals and their respective pharmacies. Amongst the regions, North America accounts for the largest regional share in the global glaucoma treatment market in 2018. Key factors driving the robust growth rate of North America region include Well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of glaucoma in the region.

The report titled “Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)” has covered and analyzed the potential of Global Glaucoma Treatment Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global glaucoma treatment. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Glaucoma Treatment Market (Actual Period: 2013-2017, Forecast Period: 2018-2023
Global Glaucoma Treatment Market – Size, Growth, Forecast
By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others
By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others)
By Sales Channel – Hospital Pharmacy, Retail Pharmacy, Others

Regional Markets – North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Glaucoma Treatment Market – Size, Growth, Forecast
By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others)
By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others)
By Sales Channel – Hospital Pharmacy, Retail Pharmacy, Others

Country Analysis - U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Glaucoma Treatment Market – Size, Growth, Forecast
By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others)
By Sales Channel – Hospital Pharmacy, Retail Pharmacy, Others

Other Report Highlights
Market Dynamics – Drivers and Restraints
Market Trends
Porter Five Force Analysis
Policy and Regulatory Landscape
Competitive Landscape
Company Analysis – Allergan, Pfizer, Novartis, Aerie Pharmaceuticals, Ocular Therapeutix, Teva Pharmaceuticals.

Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.


1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Glaucoma Treatment Market Overview
5. Global Glaucoma Treatment: Growth and Forecast
5.1 By Value (2013-2017)
Table 1: Global Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
5.2 By Value (2018-2023)
Table 2: Global Glaucoma Treatment Market Size, By Value, Forecast, 2018-2023(USD Million)
Table 3: Global Leading Cause of Blindness
Table 4: Global Prevalence of Glaucoma (2013,2020F, 2040F, Million)
Table 5: Global Diabetes Prevalence (2017 & 2045, Million)
Table 6: Population ages 65 and above, By Select Region, 2013-2017 (% of total)
Table 7: Projected global population aged 60 years & above (In Billions)
Table 8: Projected global population (In Billions)
Table 9: Global Health Expenditure Per Capita, By Select Countries,(2016, USD)
Table 10: Global Health Expenditure Per Capita, (2012-2016, USD Trillion)
Table 11: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Table 12: GDP Per Capita PPP, By Select Countries, 2022F (USD)
6. Global Glaucoma Treatment Market: Analysis By Indication
6.1 Global Glaucoma Treatment Market-By Indication: Breakdown(%)
6.1.1 Global Glaucoma Treatment Market Size and Share, By Indication, 2017
Table 13: Global Glaucoma Treatment Market Size, By Indication, 2017 (%)
6.1.2 Global Glaucoma Treatment Market Size and Share, By Indication, 2023
Table 14: Global Open Angle Glaucoma Treatment Market Size , By Type, 2023F (%)
6.2 Global Open Angle Glaucoma Treatment Market Overview
6.2.1 By Value (2013-2023)
Table 15: Global Open Angle Treatment Market, By Value, 2013-2017 (USD Million)
Table 16: Global Open Angle Treatment Market, By Value, Forecast, 2018-2023(USD Million)
Table 17: Global Prevalence of Glaucoma, By Type (2013,2015& 2020F, Million)
6.3 Global Closed Angle Glaucoma Treatment Market Overview
6.3.1 By Value (2013-2023)
Table 18: Global Closed Angle GlaucomaaTreatment Market, By Value, 2013-2017 (USD Million)
Table 19: Global Closed Angle Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
6.4 Global Secondary Glaucoma Treatment Market Overview
6.4.1 By Value (2013-2023)
Table 20: Global Secondary Glaucoma Treatment Market, By Value, 2013-2017 (USD Million)
Table 21: Global Secondary Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
6.5 Global Congenital Glaucoma Treatment Market Overview
6.5.1 By Value (2013-2023)
Table 22: Global Congenital Glaucoma Treatment Market, By Value, 2013-2017 (USD Million)
Table 23: Global Congenital Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
6.6 Global Others Glaucoma Treatment Market Overview
6.6.1 By Value (2013-2023)
Table 24: Global Others Glaucoma Treatment Market, By Value, 2013-2017 (USD Million)
Table 25: Global Others Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
7. Global Glaucoma Treatment Market: Analysis By Drug Class
7.1 Global Glaucoma Treatment Market: By Drug Class: Breakdown(%)
7.1.1 Global Glaucoma Treatment Market Size and Share, Market-By Drug Class, 2017
Table 26: Global Glaucoma Treatment Market Size, By Drug Class , 2017 (%)
7.1.2 Global Glaucoma Treatment Market Size and Share, Market-By Drug Class ,2023
Table 27: Global Glaucoma Treatment Market Size, By Drug Class 2023F (%)
7.2 Global Prostaglandin Analogs Glaucoma Treatment Market Overview
7.2.1 By Value (2013-2023)
Table 28: Global Prostaglandin Analogs Glaucoma Treatment Market, By Value, 2013-2017 (USD Million)
Table 29: Global Prostaglandin Analogs Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
Table A: List of Prostaglandin Analogs Available in Market
7.2 Global Beta Blockers Glaucoma Treatment Market Overview
7.2.1 By Value (2013-2023)
Table 30: Global Beta Blockers Glaucoma Treatment Market, By Value, 2013-2017 (USD Million)
Table 31: Global Beta Blockers Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
Table B: List of Beta Blockers Available in Market
7.3 Global Alpha Agonist Glaucoma Treatment Market Overview
7.3.1 By Value (2013-2023)
Table 32: Global Alpha Agonist Glaucoma Treatment Market, By Value, 2013-2017 (USD Million)
Table 33: Global Alpha Agonist Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
Table C: List of Alpha Agonists Available in Market
7.4 Global Carbonic Anhydrase Inhibitors Glaucoma Treatment Market Overview
7.4.1 By Value (2013-2023)
Table 34: Global Carbonic Anhydrase Inhibitors Glaucoma Treatment Market, By Value, 2013-2017 (USD Million)
Table 35: Global Carbonic Anhydrase Inhibitors Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
Table D: List of Carbonic Anhydrase Inhibitors Available in Market
7.5 Global Others Glaucoma Treatment Market Overview
7.5.1 By Value (2013-2023)
Table 36: Global Others Glaucoma Treatment Market, By Value, 2013-2017 (USD Million)
Table 37: Global Others Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
Table 38: Global Others Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
8. Global Glaucoma Treatment: Sales Channel Analysis
8.1 Global Glaucoma Treatment Market-By Sales Channel : Breakdown(%)
8.1.1 Global Glaucoma Treatment Market Size and Share, By Sales Channel, 2017
Table 39: Global Glaucoma Treatment Market Size, By Sales Channel, 2017 (%)
8.1.2 Global Glaucoma Treatment Market Size and Share, By Sales Channel, 2023
Table 40: Global Glaucoma Treatment Market Size, By Sales Channel, 2023 (%)
8.2 Global Hospital Pharmacy Glaucoma Treatment Market Overview
8.2.1 By Value (2013-2023)
Table 41: Global Hospital Pharmacy Glaucoma Treatment Market, By Value, 2013-2017 (USD Million)
Table 42: Global Hospital Pharmacy Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
8.3 Global Retail Pharmacy Glaucoma Treatment Market Overview
8.3.1 By Value (2013-2023)
Table 43: Global Retail Pharmacy Glaucoma Treatment Market, By Value, 2013-2017 (USD Million)
Table 44: Global Retail Pharmacy Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
8.4 Global Others Glaucoma Treatment Market Overview
8.4.1 By Value (2013-2023)
Table 45: Global Others Glaucoma Treatment , By Value, 2013-2017 (USD Million)
Table 46: Global Others Glaucoma Treatment Market, By Value, Forecast, 2018-2023(USD Million)
9. Global Glaucoma Treatment Market: Regional Analysis
9.1 Global Glaucoma Treatment Market, By Region: Breakdown (%)
9.1.1 Global Glaucoma Treatment Market Size, By Region, 2017 (%)
Table 47: Global Glaucoma Treatment Market Size and Share, By Region, 2017
9.1.2 Global Glaucoma Treatment Market Size, By Region, 2023 (%)
Table 48: Global Glaucoma Treatment Market Size and Share, By Region, 2023F
9.2 North America Glaucoma Treatment Market: An Analysis
9.2.1 By Value (2013-2017)
Table 49: North America Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 50: North America Population above 65 year in Million (2015 &2030F&2050F)
Table 51: North America Glaucoma Treatment Market Size, By Value, Forecast, 2018-2023(USD Million )
Table 52: North America GDP, 2012-2016 (USD Trillion)Table 49: North America Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 50: North America Population above 65 year in Million (2015 &2030F&2050F)
Table 51: North America Glaucoma Treatment Market Size, By Value, Forecast, 2018-2023(USD Million )
Table 52: North America GDP, 2012-2016 (USD Trillion)
9.2.2 By Value (2018-2023)
Table 53: North America GDP per capita, current prices, 2013-2023F (In USD)
9.3 North America Glaucoma Treatment Market: Segment Analysis
9.3.1 North America Glaucoma Treatment Market: By Indication , By Value(2013-2023)
Table 54: North America Glaucoma Treatment Market: By Indication , By Value, 2013-2023 (USD Million)
9.3.2 North America Glaucoma Treatment Market: By Drug Class , By value (2013-2023)
Table 55: North America Glaucoma Treatment Market: By Drug Class , By Value, 2013-2023 (USD Million)
9.3.4 North America Glaucoma TreatmentMarket: By Sales Channel, By Value (2013-2023)
Table 56: North America Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
Table 57: North America Glaucoma Treatment Market, Country Share, 2017 (% of Total)
Table 58: North America Glaucoma Treatment , Country Share, 2023F (% of Total)
9.4 North America Glaucoma Treatment Market: Country Analysis (U.S. and Canada)
9.4.1 U.S. Glaucoma Treatment Market, By Value (2013-2023)
Table 59: United States Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 60: United States Glaucoma Treatment Market Size, By Value, 2018E-2023F (USD Million)
Table 61: Number of adults with glaucoma in the U.S. in 2017, By Age
Table 62: United States Prevalence of Primary Open Angle Glaucoma (2013,2015& 2020F, Million)
Table 63: USA Average Household Expenditure on Healthcare (2014-2017,USD)
Table 64: Per Capita Healthcare Expenditure in United States (2012-2016, USD)
Table 65: U.S. Population Ages 65 and above, 2014 and Forecast (Million)
Table 66: USA health Spending by Type of Services or Products(2017)
Table 67: Major U.S. Players in Glaucoma Treatment Market
9.4.1.1 U.S. Glaucoma Treatment Market, By Indication, By Value (2013-2023
Table 68: United States Glaucoma Treatment Market: By Indication , By Value, 2013-2023 (USD Million)
9.4.1.2 U.S. Glaucoma Treatment, By Sales Channel, By Value (2013-2023)
Table 69: United States Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
Table 70: Top 10 Largest Retail Pharmacies by Number of Stores
Table 71: Leading Drug stores in the United States in 2017, based on Retail Sales (in billion U.S. dollars)
Table 72: Pharmacy and drug store sales in the United States from 2012 to 2017 (in USD billion)
9.4.2 Canada Glaucoma Treatment Market, By Value (2013-2023)
Table 73: Canada Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 74: Canada Glaucoma Treatment Market Size By Value, 2018E-2023F (USD Million)
Table 75: Canada Population 65 Years & Above (% of Total), 2012-2016
Table 76: Canada Life Expectancy at birth rate (Years), 2012-2015
Table 77: Prevalence of Glaucoma in Canada (2012-2016)
9.4.2.1 Canada Glaucoma Treatment Market, By Indication, By Value (2013-2023)
Table 78: Canada Glaucoma Treatment Market: By Indication , By Value, 2013-2023 (USD Million)
9.4.2.2 Canada Glaucoma TreatmentMarket, By Sales Channel By Value (2013-2023)
Table 79: Canada Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
Table 80: Canada, Growth of retail prescriptions, 2013-2017 (%)
Table 81: Leading Store chains in Canada, 2016
Table 82: Distribution of Pharmacies in Canada By Category
Table 83: Number of pharmacies and drug stores in Canada in 2016, by employment size
9.5 Europe Glaucoma Treatment Market: An Analysis
9.5.1 By Value (2013-2017)
Table 84: Europee Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
9.5.2 By Value (2018-2023)
Table 85: Europe Glaucoma Treatment Market Size, By Value, Forecast, 2018-2023(USD Million )
9.6 Europe Glaucoma Treatment Market: Segment Analysis
9.6.1 Europe Glaucoma Treatment Market: By Indication
Table 86: Europe Glaucoma Treatment Market: By Indication , By Value, 2013-2023 (USD Million)
9.6.2 Europe Glaucoma Treatment Market: By Drug Class
Table 87: North America Glaucoma Treatment Market: By Drug Class , By Value, 2013-2023 (USD Million)
9.6.3 Europe Glaucoma TreatmentMarket: By Sales channel
Table 88: Europe Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
Table 89: Number of Pharmacies in Europe 2016
Table 90: Europe Glaucoma Treatment Market, Country Share, 2017 (% of Total)
Table 91: Europe Glaucoma Treatment Market, Country Share, 2023 (% of Total)
9.7 Europe Glaucoma Treatment Market: Country Analysis (Germany, U.K., Rest of Europe)
9.7.1 Germany Glaucoma Treatment Market, By Value (2013-2023)
Table 92: Germany Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 93: Germany Glaucoma Treatment Market Size By Value, 2018E-2023F (USD Million)
Table 94: Germany Old Age Population(% of Total Population,2013-2016)
Table 95: Germany Healthcare Expenditure ( USD Billion ,2014-2017)
Table 96: Prevalence of Glaucoma in Germany (2012-2016 )
9.7.1.1 Germany Glaucoma Treatment Market, By Indication, By Value (2013-2023)
Table 97: Germany Glaucoma Treatment Market: By Indication , By Value, 2013-2023 (USD Million)
9.7.1.2 Germany Glaucoma Treatment Market, By Sales Channel, By Value (2013-2023)
Table 98: Germany Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
Table 99: Germany, Market Share of Leading Organized Pharmacy Chains
Table 100: Germany, Type of pharmacies
Table E: Germany, Number of Community Pharmacies, By State 2016
9.7.2 United Kingdom Glaucoma Treatment Market, By Value (2013-2023)
Table 101: United Kingdom Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 102: United Kingdom Glaucoma Treatment Market Size By Value, 2018E-2023F (USD Million)
Table 103: United Kingdom Glaucoma Prevalence (2012-2016)
Table 104: United Kingdom Pharmaceutical Consumption, Daily Dosage per 1000 inhabitants per Day
Table 105: U.K, Population Ages 65 and Above (% of total), 2012-2017
Table 106: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Table 107: Value of healthcare costs linked directly to Eye health in the United Kingdom (UK) in 2016 (in million GBP)
9.7.2.1 United Kingdom Glaucoma Treatment Market, By Indication, By Value (2013-2023)
Table 108: United Kingdom Glaucoma Treatment Market: By Indication , By Value, 2013-2023 (USD Million)
9.7.2.2 United Kingdom Glaucoma Treatment Market, By Sales Channel; , By Value(2013-2023)
Table 109: United Kingdom Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
Table 110: United Kingdom, Market Share of Leading Organized Pharmacy Chains
9.7.4 Rest of Europe Glaucoma Treatment Market, By Value (2013-2023)
Table 111: Rest of Europe Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 112: Rest of Europe Glaucoma Treatment Market Size By Value, 2018E-2023F (USD Million)
Table 113: Asia Pacific Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 114: Population ages 65 and above, APAC Region, By Select Countries, 2016 (% of total)
Table 115: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
9.8 Asia Pacific Glaucoma Treatment Market: An Analysis
9.8.1 By Value (2013-2017)
9.8.2 By Value (2018-2023)
Table 116: Asia Pacific Glaucoma Treatment Market Size, By Value, Forecast, 2018-2023(USD Million )
9.9 Asia Pacific Glaucoma Treatment Market: Segment Analysis
9.9.1 Asia Pacific Glaucoma Treatment Market: By Indication
Table 117: Asia Pacific Glaucoma Treatment Market: By Indication , By Value, 2013-2023 (USD Million)
9.9.2 Asia Pacific Glaucoma Treatment Market: By Drug Class
Table 118: Asia Pacific Glaucoma Treatment Market: By Drug Class , By Value, 2013-2023 (USD Million)
9.9.3 Asia Pacific Glaucoma TreatmentMarket: By Sales Channel
Table 119: Asia Pacific Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
Table 120: Asia Pacific Glaucoma Treatment Market, Country Share, 2017 (% of Total)
Table 121: Asia Pacific Glaucoma Treatment , Country Share, 2023 (% of Total)
9.10 Asia Pacific Glaucoma Treatment Market: Country Analysis (India, China Japan & Rest of Asia Pacific)
9.10.1 China Glaucoma Treatment Market, By Value (2013-2023)
Table 122: China Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 123: China Glaucoma Treatment Market Size By Value, 2018E-2023F (USD Million)
9.10.1.1 China Glaucoma Treatment Market, By Indication, By Value (2013-2023)
Table 124: China Glaucoma Treatment Market: By Indication , By Value, 2013-2023 (USD Million)
9.10.1.2 China Glaucoma Treatment Market, By Sales Channel, By Value (2013-2023)
Table 125: China Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
Table 126: Number of pharmacists in China, 2016
Table 127: China, Market Share of Leading Organized Pharmacy Chains
9.10.2 Japan Glaucoma Treatmentes Market, By Value (2013-2023)
Table 128: Japan Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 129: Japan Glaucoma Treatment Market Size By Value, 2018E-2023F (USD Million)
9.10.2.1 Japan Glaucoma Treatment Market, By Indication, By Value (2013-2023)
Table 130: Japan Glaucoma Treatment Market: By Indication , By Value, 2013-2023 (USD Million)
9.10.2.3 Japan Glaucoma TreatmentMarket, By Sales Channel, By value(2013-2023)
Table 131: Japan Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
Table 132: Total number of Pharmacists Engaged in Medical Care in Japan from 2012 to 2016 (in 1,000s)
9.10.3 India Glaucoma Treatment Market, By Value (2013-2023)
Table 133: India Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 134: India Glaucoma Treatment Market Size By Value, 2018E-2023F (USD Million)
Table 135: India Old Age population ( % of Total Population)
Table 136: Diabetes Fact Sheet India 2017
9.10.3.1 India Glaucoma Treatment Market, By Indication, By Value (2013-2023)
Table 137: India Glaucoma Treatment Market: By Indication , By Value, 2013-2023 (USD Million)
9.10.3.2 India Glaucoma Treatment Market, By Sales Channel, By Value (2013-2023)
Table 138: India Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
9.10.4 Rest of Asia Pacific Glaucoma Treatment Market, By Value (2013-2023)
Table 139: Rest of Asia Pacific Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 140: Rest of Asia Pacific Glaucoma Treatment Market Size By Value, Forecast, 2018-2023(USD Million)
9.11 Rest of World Glaucoma Treatment Market: An Analysis
9.11.1 By Value (2013-2017)
Table 141: Rest of world Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
9.11.2 By Value (2018-2023)
Table 142: Rest of World Glaucoma Treatment Market Size, By Value, Forecast, 2018-2023(USD Million )
9.12 Rest of World Glaucoma Treatment Market: Segment Analysis
9.12.1 Rest of World Glaucoma Treatment Market: By Indication, By Value(2013-2023)
Table 143: Rest of World Glaucoma Treatment Market: By Indication , By Value, 2013-2017 (USD Million)
9.12.2 Rest of World Dental System and Parts Market: By Drug Class n, By Value(2013-2023)
Table 144: Rest of World Glaucoma Treatment Market: By Drug Class , By Value, 2013-2023 (USD Million)
9.12.3 Rest of World Glaucoma Treatment Market: By Sales Channel, By Value(2013-2023)
Table 145: Rest of World Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
Table 146: Rest of world Glaucoma Treatment Market, Country Share, 2017 (% of Total)
Table 147: Rest of World Glaucoma Treatment , Country Share, 2023F (% of Total)
9.13 Rest of World Glaucoma Treatment Market: Country Analysis (Brazil & Others)
9.13.1 Brazil Glaucoma Treatment Market, By Value (2013-2023)
Table 148: Brazil Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 149: Brazil Glaucoma Treatment Market Size, By Value, 2018E-2023F (USD Million)
9.13.1.1 Brazil Glaucoma Treatment Market, By Indication, By Value (2013-2023)
Table 150: Brazil Glaucoma Treatment Market: By Indication , By Value, 2013-2017 (USD Million)
9.13.1.2 Brazil Glaucoma Treatment Market: By Sales Channel, By Value(2013-2023)
Table 151: Brazil Glaucoma Treatment Market: By Sales Channel , By Value, 2013-2017 (USD Million)
9.13.3 Others Glaucoma Treatment Market, By Value (2013-2023)
Table 152: Other Glaucoma Treatment Market Size, By Value, 2013-2017 (USD Million)
Table 153: Other Glaucoma Treatment Market Size By Value, 2018E-2023F (USD Million)
Table 154: Percentage aged 60 years and over, (2000, 2015, 2030, 2050)
Table 155: Global Healthcare Expenditure, 2012-2016 (In Trillion)
Table 156: Global Glaucoma Treatment Market Share Analysis, By Company Share, 2017 (%)
Table 157: Sales of Alphagan/Combigan (2015-2017 , USD Million)
Table 158: Sales of Lumigan/Ganfort (2015-2017 , USD Million)
Table 159: Sales of Xalatan/Xalacom (2015-2017 , USD Million)
10. Market Dynamics
10.1 Drivers
10.2 Challenges
11. Market Trends
12. Competitive Landscape
13. Policy and Regulatory Landscape
14. Porter’s Five Forces Analysis
15. SWOT Analysis
16. Company Profiles
16.1 Teva Pharmaceuticals
Table 160: Teva Pharmaceuticals, Revenue, 2015-2017 (USD Millions)
Table 161: Teva Pharmaceuticals Segmental Breakup, 2017(%)
Table 162: Teva Pharmaceuticals Sales, By Region 2017 (%)
16.2 Ocular Therapeutix
Table 163: Ocular Therapeutix, Revenue, 2015-2017 (USD Thousands)
16.3 Pfizer
Table 164: Pfizer, Revenue, 2015-2017 (USD Millions)`
Table 165: Pfizer Segmental Breakup, 2017(%)
Table 166: Pfizer Sales, By Country, 2017 (%)
16.4 Bausch Health
Table 167: Bausch Health, Revenues, 2015-2017 (USD Million)
Table 168: Bausch Health , Revenue, By Segment, 2017 (%)
Table 169: Bausch Health, Revenue, By Region, 2017 (%)
16.5 Novartis
Table 170: Novartis, Sales, 2013-2017 (USD Millions)
Table 171: Novartis Sales, By Segment 2017 (%)
Table 172: Novartis Sales, By Geography,2017 (%)
16.6 Allergan Plc.
Table 173: Allergan Net Sales, By Geographic Location, % Share 2016
Table 174: Allergan Net Revenue, By Business Segment,% Share 2017
Table 175: Allergan Net Revenue, 2014-2017 (USD Billion)
16.7 Aerie Pharmaceuticals
Table 176: Aerie Pharmaceuticals Global Pipeline
16.8 Akorn Inc.
Table 177: Akorn Inc. Net Revenue, By Business Segment,% Share 2017
Table 178: Akorn Inc. Net Revenue, 2014-2017 (USD Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report